BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

The GREENFUND - we're buying the dip, big time, and here's why., page-160

  1. 4,077 Posts.
    lightbulb Created with Sketch. 477
    I've seen relistings on the NSDAQ go horribly wrong (think MSB). It's not a necessary risk. Good results and progress to a Phase III for acne will see the price recover.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.